Role of GDF-15 in diabetic nephropathy: mechanisms, diagnosis, and therapeutic potential

被引:1
|
作者
Zhang, Xin [1 ]
Zhou, Chen-gang [1 ]
Ma, Li-jia [1 ,2 ]
机构
[1] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Clin Lab, Shanghai 201100, Peoples R China
[2] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Pathol Dept, Shanghai 201100, Peoples R China
关键词
Circulating growth differentiation factor 15; Diabetic nephropathy; Progression; DIFFERENTIATION FACTOR 15; PROGNOSIS; FACTOR-15; BIOMARKER; TYPE-1; IDENTIFICATION; MORTALITY; CYTOKINE; CACHEXIA; PATHWAY;
D O I
10.1007/s11255-024-04179-2
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
PurposeGrowth differentiation factor 15 (GDF-15) is a cytokine involved in regulating homeostasis, and its expression is up-regulated in response to injury, stress, and inflammation. This study explored the role of GDF-15 in diabetic nephropathy (DN), a severe complication of diabetes mellitus, and its potential as a biomarker for disease progression.MethodsAs a member of the transforming growth factor-beta superfamily, GDF-15 exhibits its renal protective functions primarily through its anti-inflammatory effects and the up-regulation of other renal protective factors. This study evaluated the association between circulating GDF-15 levels and DN progression, examining the underlying mechanisms.ResultsCirculating GDF-15 levels are closely linked to the development and progression of DN. While existing research has yielded some consistent conclusions, a comprehensive understanding of the role of GDF-15 in DN pathogenesis is needed to identify new therapeutic targets and strategies.ConclusionGDF-15 has the potential to be a prognostic and diagnostic biomarker for DN. It is crucial to establish appropriate reference ranges and explore their clinical utility in routine practice for validating the role of GDF-15 in DN management. Further interventional studies are required to confirm its clinical value in diagnosing and predicting the progression of DN.
引用
收藏
页码:169 / 175
页数:7
相关论文
共 50 条
  • [41] An Updated Review on Diabetic Nephropathy: Potential Mechanisms, Biomarkers, Therapeutic Targets and Interventional Therapies
    Nadendla, Rama Rao
    Khairunnisa, K.
    Aziz, Namra
    Pyne, Chandana
    Panigrahy, Uttam Prasad
    Wal, Pranay
    Kulkarni, Mrunalini Harish
    Rasheed, Azhar
    CURRENT DIABETES REVIEWS, 2025, 21 (09)
  • [42] Exploring the Impact of Optimized Probiotic Supplementation Techniques on Diabetic Nephropathy: Mechanisms and Therapeutic Potential
    Ghosh, Anindita
    Muley, Arti
    Ainapure, Archana S.
    Deshmane, Aditi R.
    Mahajan, Anu
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (02)
  • [43] Lipophagy: A Potential Therapeutic Target for Diabetic Nephropathy
    Yang, Ming
    Song, Panai
    Zhao, Li
    Wang, Xi
    CURRENT MEDICINAL CHEMISTRY, 2023, 30 (16) : 1875 - 1886
  • [44] The podocyte: a potential therapeutic target in diabetic nephropathy?
    Marshall, Sally M.
    CURRENT PHARMACEUTICAL DESIGN, 2007, 13 (26) : 2713 - 2720
  • [45] Autophagy and its therapeutic potential in diabetic nephropathy
    Han, Yu-Peng
    Liu, Li-Juan
    Yan, Jia-Lin
    Chen, Meng-Yuan
    Meng, Xiang-Fei
    Zhou, Xin-Ru
    Qian, Ling-Bo
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [46] Immuno-suppressive role of tumour-derived GDF-15 on myeloid cells
    Schuberth-Wagner, C.
    Giese, I.
    Kist, M.
    Vashist, N.
    Genssler, S.
    Haack, B.
    Weigandt, J.
    Auer, M.
    Wischhusen, J.
    Klar, K.
    Leo, E.
    Haake, M.
    ANNALS OF ONCOLOGY, 2023, 34 : S190 - S190
  • [47] Towards a multimarker prognostic strategy in acute heart failure. A role for GDF-15
    Bettencourt, P.
    Pinto, M. J.
    Rodrigues, P.
    Marques, P.
    Moreira, H.
    Guimaraes, J. T.
    Lourenco, P.
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 38 - 38
  • [48] THE ROLE OF CXCL4, CXCL8 AND GDF-15 IN SYSTEMIC SCLEROSIS
    Oller Rodriguez, J. E.
    Grau Garcia, E.
    Gonzalez Mazario, R.
    De la Rubia Navarro, M.
    Pavez Perales, C.
    Leal Rodriguez, S.
    Martinez Cordellat, I.
    Ortiz Sanjuan, F. M.
    Vicens Bernabeu, E.
    Negueroles Albuixech, R.
    Chalmeta Verdejo, I.
    Alcaniz Escandell, C.
    Fragio-Gil, J. J.
    Canovas Olmos, I.
    Najera Herranz, C.
    Gonzalez Puig, L.
    Ivorra Cortes, J.
    Hervas Marin, D.
    Roman Ivorra, J. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1378 - 1379
  • [49] The potential role of prorenin in diabetic nephropathy
    Schmieder, Roland E.
    JOURNAL OF HYPERTENSION, 2007, 25 (07) : 1323 - 1326
  • [50] GDF-15 and sST-2 act as biomarkers of disease severity but not independent predictors in idiopathic membranous nephropathy
    Wu, Lina
    Luo, Lin
    Zhou, Li
    Li, Na
    Qin, Xiaosong
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 111